LoginSignup
Lantheus Hldg logo

Lantheus Hldg Stock

StockStock
ISIN: US5165441032
Ticker: LNTH
US5165441032
LNTH

Price

Frequently asked questions

What is Lantheus Hldg's market capitalization?

The market capitalization of Lantheus Hldg is $7.59B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Lantheus Hldg's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Lantheus Hldg is 17.91. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Lantheus Hldg?

Lantheus Hldg's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $6.107. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Lantheus Hldg's stock?

Currently, 10 analysts cover Lantheus Hldg's stock, with a consensus target price of $104.90. Analyst ratings provide insights into the stock's expected performance.

What is Lantheus Hldg's revenue over the trailing twelve months?

Over the trailing twelve months, Lantheus Hldg reported a revenue of $1.44B.

What is the EBITDA for Lantheus Hldg?

Lantheus Hldg's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $512.89M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Lantheus Hldg?

Lantheus Hldg has a free cash flow of $321.50M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Lantheus Hldg's stock?

The 5-year beta for Lantheus Hldg is 0.51. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Lantheus Hldg have, and what sector and industry does it belong to?

Lantheus Hldg employs approximately 834 people. It operates in the Health Care sector, specifically within the Medical Equipment & Supplies industry.

What is the free float of Lantheus Hldg's shares?

The free float of Lantheus Hldg is 67.69M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $7.59B

5Y beta

 0.51

EPS (TTM)

 $6.107

Free Float

 67.69M

P/E ratio (TTM)

 17.91

Revenue (TTM)

 $1.44B

EBITDA (TTM)

 $512.89M

Free Cashflow (TTM)

 $321.50M

Pricing

1D span
$107.04$110.39
52W span
$50.20$126.89

Analyst Ratings

The price target is $104.90 and the stock is covered by 10 analysts.

Buy

9

Hold

1

Sell

0

Information

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic candidates help healthcare professionals (HCPs) find, fight, and follow cancer, with a focus in prostate cancer. Its pipeline also includes breast and other cancers. Its Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Its Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma solutions platforms. Its commercial products include PYLARIFY, DEFINITY, Ga-DOTA-RM2, and others. Its pipeline includes B amyloid positron emission tomography (PET) imaging agent, NAV-4694, also known as F18-flutafuranol.

834

Medical Equipment & Supplies

Health Care

Identifier

ISIN

US5165441032

Primary Ticker

LNTH

Knockouts

Join the conversation
Sign upLogin